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Abstract Membrane transport proteins transduce free energy
stored in electrochemical ion gradients into a concentration gra-
dient and are a major class of membrane proteins, many of
which play important roles in human health and disease. Re-
cently, the X-ray structure of the Escherichia coli lactose per-
mease (LacY), an intensively studied member of a large group
of related membrane transport proteins, was solved at 3.5 A$ .
LacY is composed of N- and C-terminal domains, each with six
transmembrane helices, symmetrically positioned within the
molecule. The structure represents the inward-facing conforma-
tion, as evidenced by a large internal hydrophilic cavity open to
the cytoplasmic side. The structure with a bound lactose homo-
log reveals the sugar-binding site in the cavity, and a mechanism
for translocation across the membrane is proposed in which the
sugar-binding site has alternating accessibility to either side of
the membrane.
) 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
LacY is encoded by the lacY gene, the second structural
gene in the lac operon [1], and is solely responsible for all
the translocation reactions that typify the galactoside trans-
port system in Escherichia coli (reviewed in [2]). LacY is a
particularly well-studied representative of the major facilitator
superfamily (MFS) [3] which presently contains more than
1000 members [4]. Like many MFS members, LacY transdu-
ces the free energy released from the downhill translocation of
Hþ in response to an electrochemical Hþ gradient (interior
negative and/or alkaline) to drive the uphill stoichiometric
accumulation of galactosides against a concentration gradient.
Conversely, LacY can also transduce the free energy released
from the downhill translocation of galactosides to drive the
uphill stoichiometric translocation of Hþ with the generation
of a Hþ electrochemical gradient, the polarity of which de-
pends upon the direction of the substrate concentration gra-
dient.
The use of molecular biological approaches to engineer
LacY for site-directed biochemical and biophysical studies
has provided insight into both structure and mechanism (re-
viewed in [2,5]). In addition to other site-directed mutants,
functional LacY devoid of eight native Cys residues (C-less
LacY) has been constructed and used for Cys-scanning muta-
genesis [5]. Analysis of the mutants has yielded the following
information: (i) Almost all of the mutants are expressed nor-
mally in the membrane and have signi¢cant activity. (ii) Re-
markably, only six side chains are irreplaceable with respect to
active transport: Glu126 (helix IV) and Arg144 (helix V),
which are crucial for substrate binding; Glu269 (helix VIII),
which may be involved in both substrate binding and Hþ
translocation; and Arg302 (helix IX), His322, and Glu325
(helix X), which play essential roles in Hþ translocation. (iii)
Positions accessible to solvent have been identi¢ed. (iv) Posi-
tions where the reactivity of the Cys replacement is increased
or decreased by ligand have been identi¢ed. (v) LacY is highly
£exible conformationally. (vi) A low-resolution 3D structural
model has been proposed based on the results of thiol cross-
linking experiments and engineered Mn(II)-binding sites [6].
(vii) A model for the transport mechanism has been formu-
lated on the basis of structural data and the properties of
mutants in the irreplaceable residues [2].
This discussion includes the overall X-ray structure of
LacY, the sugar-binding site and an alternating access model
for sugar translocation across the membrane. Discussion of
residues involved in Hþ translocation and coupling and de-
scription of a more detailed mechanism for galactoside/Hþ
symport are omitted here for brevity. For these aspects of
the work, the reader is referred to references [2] and [7].
A mutant of LacY with Gly in place of Cys154
(Cys154CGly; C154G) is arrested in one conformation [8^
10], and crystals of this mutant that di¡ract well have been
grown successfully, leading to an X-ray structure of an in-
ward-facing conformation of LacY with bound substrate [7]
(Fig. 1). The structure clearly shows the overall fold of
LacY, which is composed of unusually distorted helices and
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a large water-¢lled internal cavity, as well as the details of the
sugar-binding site. The structure is highly consistent with the
proposed inward-facing conformation of LacY (see [2]).
With regard to the phenotype of the C154G mutant, helices
I and V cross in the approximate middle of the membrane
where Cys154 is in close proximity to Glu24 (Fig. 1). Thus,
replacement of Cys154 with Gly may cause the two helices to
come into closer approximation, as suggested for glycophorin
A dimerization [11], thereby causing the phenotype. Evidence
supporting this interpretation is provided by the demonstra-
tion that introduction of mutant G24C into the C154G muta-
tion rescues active transport to a highly signi¢cant extent
(N. Ermolova, I. Smirnova and H.R. Kaback, unpublished
observations).
2. Overall structure
Structures were solved with and without the high-a⁄nity lactose
homolog L-D-galactopyranosyl-1-thio-L-D-galactopyranoside (TDG).
Unexpectedly, an unidenti¢ed disaccharide of unknown origin was
found in the sugar-binding site at s 50% occupancy when the protein
was crystallized without TDG. The two structures show little di¡er-
ence except for some minor alterations in the sugar-binding site.
The asymmetric unit of the LacY crystal is composed of an arti¢cial
dimer, with two molecules oriented in opposite directions, con¢rming
the monomer as the functional unit of LacY (see [12^14]). The struc-
tures of the two monomers are almost identical. Viewed parallel to the
membrane (Fig. 1A), the monomer is heart-shaped with an internal
cavity open on the cytoplasmic side and largest dimensions of 60 AR
(along the membrane) by 60 AR (along the membrane normal). Normal
to the membrane (Fig. 1B), the molecule is oval-shaped with dimen-
sions of 30 AR by 60 AR . Biochemical studies [13^15] estimate that the
thickness of the bilayer is ca. 27 AR (Fig. 1A). A large interior hydro-
philic cavity open only at the cytoplasmic side is observed with di-
mensions of 25 AR by 15 AR , indicating that the structure represents the
inward-facing conformation (Fig. 2). Within the cavity, TDG binds at
a site that is a similar distance from both sides of the membrane, and
the periplasmic side is closed tightly. This is consistent with the notion
that LacY has only one binding site that is alternately accessible to
each side of the membrane. In this context, it is noteworthy that the
Pi/glycerol-3-P antiporter (GlpT), another member of the MFS, has a
similar structure, and the substrate-binding site is postulated to be in a
similar location [16].
3. Transmembrane helix packing and domain structure
The monomer contains 12 transmembrane helices, as pre-
dicted [17,18]. The N- and C-terminal six helices form two
distinct helical bundles connected by a long loop between
helices VI and VII (Fig. 1). Although loop VI/VII has two
Fig. 1. Overall structure of LacY. The ¢gures are based on the C154G mutant structure with a bound substrate homolog, TDG. A: Ribbon
representation of LacY viewed parallel to the membrane. The 12 transmembrane helices are colored from the N-terminus in purple to the C-
terminus in dark pink; TDG is represented by black spheres, and the membrane is in pale yellow. B: LacY in a ribbon representation, viewed
along the membrane normal from the cytoplasmic side. For clarity, the loop regions have been omitted. The color scheme is the same as in A;
the 12 transmembrane helices are labeled with Roman numerals.
Fig. 2. The internal hydrophilic cavity of LacY. The surface model and electrostatic potential were calculated with the program GRASP [37].
The polar surfaces are colored blue (positively charged) and red (negatively charged). The black spheres denote TDG. A: View parallel to the
membrane. For clarity, helices V and VIII have been removed. The membrane is in pale yellow. B: View along the membrane normal from the
cytoplasmic side.
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short helical segments at the N- and C-terminal, it is extended
and £exible. The N- and C-terminal six-helix domains have
the same topology and are related by an approximate two-
fold symmetry (Fig. 1B), as shown also with GlpT [16] and
OxlT and proposed for other MFS transporters [19]. The high
degree of symmetry between the N- and C-terminal domains
suggests that they have the same genetic origin, although there
is low sequence homology between the two domains [20].
A hydrophilic cavity is formed between helices I, II, IV, and
V of the N-terminal domain and helices VII, VIII, X, and XI
of the C-terminal domain. Helices III, VI, IX, and XII are
largely embedded in the bilayer and not exposed to the sol-
vent. Site-directed alkylation of single-Cys residues with N-
ethylmaleimide (NEM) are entirely consistent with the pres-
ence of a large hydrophilic cavity in LacY. Accessibility of
single-Cys mutants to the highly impermeant thiol reagent
methanethiosulfonate ethylsulfonate (MTSES) [21,22] occurs
mainly at positions lining the hydrophilic cavity (Fig. 3A,B).
MTSES accessibility to Cys replacements at positions leading
from the hydrophilic cavity to the periplasmic side may rep-
resent the pathway by which sugar gains access to the binding
site.
4. The substrate-binding site
The substrate-binding site is found in the hydrophilic cavity
at a similar distance from either side of the membrane and
near the molecular two-fold axis of LacY (Figs. 1 and 2). The
residues involved in substrate binding are shown in Fig. 4A,B.
The sugar-binding site in the N-terminal domain is composed
of residues from helices I, IV, and V. In the C-terminal do-
main, helices VII and XI ^ which are symmetrically related to
helices I and V, respectively ^ form the other half of the bind-
ing site for TDG.
The binding site in the N-terminal domain bears a striking
resemblance to the sites of many other sugar-binding proteins
[23]. The primary hydrophobic interaction of the galactopyr-
anosyl ring with the indole ring of Trp151 (helix V) is a
common feature of galactoside-binding proteins. The C6
atom of the galactopyranosyl ring also appears in a van der
Waals contact with the S atom of Met23 (helix I). The irre-
placeable residue Arg144 (helix V) forms bidentate H-bonds
with the O3 and O4 atoms of the galactopyranosyl ring. An-
other irreplaceable residue, Glu126 (helix IV), is in close prox-
imity to Arg144 and may interact with the O4, O5, or O6
atoms of TDG via water molecules. However, individual
water molecules cannot be modeled at this resolution. The
results are consistent with ¢ndings that even the most conser-
vative replacement for Arg144 (Lys; R144K) abolishes bind-
ing, and replacement of Glu126 with aspartate results in sub-
stantially reduced a⁄nity (see [2]). Biochemical evidence [24^
26] suggests that these residues form a salt bridge during turn-
over, although this interaction is not observed in the current
structure. Instead, another irreplaceable residue, Glu269 (helix
VIII), appears to form a salt bridge with Arg144 as well as a
possible H-bond with Trp151. All replacements for Glu269,
with the sole exception of aspartic acid, are defective with
respect to substrate binding and all translocation reactions
[27,28]. Glu269 in helix VIII in the C-terminal domain is the
only residue that crosses domains and seems to be key in
providing the important energetic link between the N- and
C-terminal helix domains [29].
Recent studies (J. Vazquez-Ibar, L. Guan, M. Svrakic and
H.R. Kaback, in preparation) utilizing a mutant with a single-
Trp residue at position 151 are highly consistent with the
conclusions drawn from the structure. Puri¢ed single-Trp151
LacY exhibits an emission maximum at 340 nm, consistent
with an aqueous local environment, and addition of LacY
Fig. 3. Accessibility of Cys-replacement mutants to water. Individual
Cys-replacement mutants were labeled with [14C]NEM before and
after treatment with MTSES, an impermeant thiol reagent, as de-
scribed in [22,38^41]. In A, the membrane is in pale yellow.
Fig. 4. Substrate-binding site of LacY. Possible H-bonds and salt bridges are represented by dashed black lines. Transmembrane helices in the
N- and C-terminal domains are colored blue and red, respectively. Color code for atoms: white, carbon in side chains; black, carbon in TDG;
blue, nitrogen; red, oxygen; green, sulfur. A: Residues involved in TDG binding viewed along the membrane normal from the cytoplasmic
side; a 2MFobsM3MFcalcM electron density map (contoured at 1.5) for TDG is also shown (green). B: Closer view of the TDG-binding site in the
N-terminal domain.
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substrates induces a 3^4 nm blue shift with an increase in
£uorescence. Moreover, quenching by cesium, iodide or acryl-
amide is inhibited in the presence of TDG, and Trp phosphor-
escence is red-shifted by 3^4 nm in the presence of LacY
substrates. In addition, when Glu269 is replaced with Asp,
the £uorescence emission maximum is red-shifted by 9^10
nm, indicating that Trp151 is even more accessible to water.
Alkylation of Cys148 inactivates LacY by blocking sugar
binding, and Cys148 is protected from alkylation with NEM
by LacY substrates (see [2]). In similar fashion, alkylation of
mutant A122C (helix IV) with NEM or replacement with Phe
or Tyr abolishes binding and transport of disaccharide sub-
strates speci¢cally with hardly any e¡ect on galactose binding
or transport [30]. Cys148 and Ala122 are found in the vicinity
of the N-terminal domain of the substrate-binding site, and
the e¡ects described are clearly explained by steric hindrance.
With regard to the C-terminal domain and TDG binding,
fewer interactions are observed. Only a single H-bond is ob-
served between Lys358 (helix XI) and the O4P atom of TDG.
Asp237 (helix VII), which forms a H-bond with Lys358, is
also in the vicinity of the O4P atom of TDG; however, inter-
action may occur via a water molecule. Other polar residues
like Gln359 (helix XI) may also be involved in binding
through water molecules, as this is a common motif for sug-
ar-binding proteins.
It is essential to realize that galactose itself is the most
speci¢c substrate for LacY but has very low a⁄nity, which
is increased markedly by various adducts at the anomeric
carbon [31]. Furthermore, the C4 OH is the most important
determinant for speci¢city [32], although the C2, C3, and C6
OH groups on the galactopyranosyl ring also play roles in H-
bonding. The hydrophobic interaction between the galacto-
pyranosyl ring and Trp151 is likely to orient the galactopyr-
anosyl ring so that important H-bonds can be formed [33].
The important portion of the substrate-binding site with re-
gard to speci¢city is in the N-terminal domain, and the resi-
dues in the C-terminal domain that interact with the second
galactopyranosyl ring in TDG (or other anomeric substitu-
ents) increase a⁄nity for disaccharide substrates but have lit-
tle or nothing to do with speci¢city.
5. An alternating accessibility model for translocation across
the membrane
The crystal structure clearly represents the protonated, in-
ward-facing conformation of LacY with bound substrate [2,7].
In this structure, the central hydrophilic cavity containing the
sugar-binding site is open toward the cytoplasmic side only.
However, an alternative, outward-facing conformation open
to the periplasm must exist for substrate translocation across
the membrane. Because the hydrophilic cavity exists between
the N- and C-terminal domains, which are connected by a
£exible loop, it seems likely that the structural change between
inward- and outward-facing conformations involves rotation
between the N- and C-terminal domains around the sugar-
binding site, thereby allowing the binding site alternating ac-
cessibility to each side of the membrane.
There is experimental support for this conclusion. The
NEM reactivity of Cys replacement mutants at the periplas-
mic side of LacY at the N- and C-terminal domain interface
increases in the presence of ligand, suggesting that this region
of LacY undergoes conformational changes that may allow
access to ligand in the outward-facing conformation (Fig.
5A). As discussed above, the crystal structure is derived
from the mutant C154G. Gly154 (helix V) is at the domain
interface, and mutation from Cys to Gly allows tighter pack-
ing at the interface, stabilizing the inward-facing conforma-
tion.
A hint for 3D modeling of the outward-facing conforma-
tion is derived from extensive thiol cross-linking studies in
which many distances were measured between positions in
the N- and C-terminal domains [6]. Many observed distances
are reasonably consistent with the X-ray structure; however,
there is a tendency for thiol cross-linking to underestimate
distances because cross-linking often traps Cys residues
when they are closest to each other [34]. At the periplasmic
side of LacY, distances monitored by cross-linking are rea-
sonably consistent with those observed in the structure. How-
ever, on the cytoplasmic side, among pairs of residues that
exhibit cross-linking, a group is observed where the distances
between residues measured by cross-linking are consistently
Fig. 5. Structural changes between inward- and outward-facing conformations. Transmembrane helices in the N- and C-terminal domains are
shown as blue and maroon cylinders, respectively. A: Inward-facing conformation (i.e. the crystal structure) viewed parallel to the membrane.
Cys replacements of the residues in yellow show an increased reactivity in NEM labeling upon substrate binding. B: A possible model for the
outward-facing conformation, based on chemical modi¢cation and cross-linking experiments (see the main text), viewed parallel to the mem-
brane. The model was obtained by applying a relative rigid-body rotation of 60‡ (around the axis passing near the TDG parallel to the mem-
brane) to the N- and C-terminal domains. The membrane is in pale yellow.
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underestimated to the extent of 10^15 AR relative to the crystal
structure. For example, on the cytoplasmic side, the distances
of residues between helix V (Phe140, Gly141, Ala143) and
helix VIII (Ile275, Phe278, Ala279) or helix X (Cys333), be-
tween helix IV (Val125, Ile129, Arg134) and helix X (Lys335,
Ser339), and between helix XI (Tyr350, Cys353, Phe354) and
helix II (Phe63, Ser67) or helix IV (Ile129, Arg134) are all
estimated to be only 9^10 AR by thiol cross-linking. Because
the conformation of LacY was not arrested in the cross-link-
ing experiments, discrepancy between distances may re£ect
£uctuations between the inward- and outward-facing confor-
mations of the molecule (Fig. 5). To ful¢ll these distances
observed in the thiol cross-linking experiments, helices II-IV-
XI, V-VIII-X, and IV-X must be closely packed together,
which is not observed in the current inward-facing conforma-
tion.
By applying a relative rotation of 60‡ between the N- and
C-terminal domains, a model for the putative outward-facing
conformation can be obtained that satis¢es the helix packing
derived from thiol cross-linking (Fig. 5B). The £exible loop
connecting N- and C-terminal domains is compatible with this
conformational change. In the model of the outward-facing
conformation, the cytoplasmic halves of helices II, IV, and V
in the N-terminal domain and helices VIII, X, and XI in the
C-terminal domain form an interface that closes the cytoplas-
mic end of the hydrophobic cavity. Interestingly, kinks at
Pro123 (helix IV) and Pro327 (helix X), which are at the
domain interface in the outward-facing conformation, are in
almost equivalent positions to the kinks at Pro28 (helix I) and
Ala244 (helix VII) at the domain interface in the inward-fac-
ing conformation. It is likely that these kinks allow tight clo-
sure of the hydrophilic cavity ends by conferring £exibility to
these helices. Each of the eight helices that form the surface of
the hydrophilic cavity is heavily distorted by kinks and bends,
and each also contains many Pro and Gly residues commonly
found in irregular helices ; in contrast, helices VI, IX, and XII,
which are not part of the cavity, are unperturbed (Fig. 1).
This ¢nding implies that the irregular helices provide struc-
tural £exibility, thereby allowing the molecule to assume dif-
ferent conformations. The irregular shapes of many of the
transmembrane helices and the dynamic conformational na-
ture of the molecule, as well as the large hydrophilic cavity,
may explain the very high rates and extent of H/D exchange
observed with LacY [35,36].
Although the alternating access model depicted implies a
symmetrical conformational change in LacY with the binding
site becoming accessible to either side via hydrophilic cavities
of approximately equal volume, the MTSES accessibility re-
sults shown in Fig. 3 suggest that the changes may not be
symmetrical. From the results shown, it appears that the peri-
plasmic side of LacY may not open to the same extent as the
cytoplasmic side. In any case, it is apparent that further bio-
chemical and computational studies based on the crystal
structure and structure determinations of the other states,
particularly the outward-facing conformation(s), will facilitate
our understanding of the transport mechanism.
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